IperionX: Strengthening Americas Titanium Supply Chain

IperionX (ASX: IPX) is a U.S.-based titanium and critical materials company advancing patented processes to produce high-performance titanium alloys more efficiently and sustainably. The company has received extensive validation and funding from multiple U.S. Department of War programs, including ARPA-E, DPA Title III, IBAS and a major SBIR Phase III contract. These awards underscore the strategic importance and technical maturity of IperionX’s technologies, which upgrade titanium minerals and scrap into high-quality metal products.

The company is scaling industrial titanium production at its Virginia manufacturing campus, targeting a significant capacity expansion by 2027. It is also progressing the Titan Critical Minerals Project—America’s largest JORC-compliant titanium, rare earth, and zircon resource—with U.S. government support. With growing commercial programs in defense, automotive, consumer electronics and aerospace, IperionX aims to deliver a fully integrated, cost-competitive and resilient domestic titanium supply chain essential to U.S. advanced manufacturing.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com